Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Many thanks for the reply GB and thanks for clarifying. This is clearly good news.
As the price dropped yesterday during a positive day in the market it appears i'm not alone here. Similarly IMHO it was poorly explained in the Proactive interview (but in defence you are usually very good in such situations).
Also whilst i understand that it is sometimes difficult to quantify certain deals recently signed it was only on 3/2 that SKIN issued a "management expects a material contribution" RNS and the headline from the recent deal with MWG was for $3.75m yet on reading it it appears it's c£400k for SKIN per year.
James - the share price has dropped c50% in the last month or so. Stop being a t*at
To clarify I thought some of the £2m would include MWG as someone enquired so that’s on top of the £2m. Onwards and upwards from an operational and fundamentals point of view but maybe not the share price, yet anyway!
I don’t look in here very often but just seen GB’s reply and I’m amazed at the reaction. £2m orders for SKIN alone is phenomenal, remember FY19 was circa £1m. Those orders will be throughout the year but it’s amazing progress, he’s doing what he says, no question. Although paper losses are never good it doesn’t matter if you believe as I’m not selling and a silver lining is the lower it goes the more I can bed into an ISA.
p.s.
cant actually buy anything :/
there you go shandy!
Anyone that can read a RNS, its all there but thanks for highlighting that. 2 million already in Q1 2020, thats what you need to know.
Thanks for the clarification Gerry. Cracking news yesterday for both SKIN & MWG, Pitty the good does not reflect in the SP but hopefully with a constant stream of positive news flow in the short to medium future it’s only a matter of time.
I am happy to help those unfamiliar with RNS Regulatory announcements. They are material statements that comply with AIM Rule 11, general disclosure of price sensitive information. This is not a statement where "management expects" or "Board expects". So, I am pleased to confirm it is £2m of confirmed orders to SKIN.
Hope that helps clarify
is this £2m rev all for SKIN or does it include partnership deals? On Proactive Interview yesterday GB was a little evasive when asked.
Reason i ask is that the recent £3m deal announced with Modern Water is actually 60% for MWG and 40% SKIN. As it's also over 3 years that's c £400k a year for SKIN.
Decent money but not quite the headline figure on the RNS
If they keep this growth up their revenue could be at least double previous projections, almost matching the Mcap. Crazy sp considering we're profiting from something that most other companies are being destroyed by.
Thats what some were waiting for. Excellent piece of news.